CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Update

CellaVision AB (publ) (OTCMKTS:CLVSFGet Free Report) saw a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 100 shares, a drop of 75.0% from the July 31st total of 400 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

CellaVision AB (publ) Stock Performance

CellaVision AB (publ) stock remained flat at $25.91 on Wednesday. CellaVision AB has a twelve month low of $20.24 and a twelve month high of $25.91. The company has a fifty day moving average price of $22.01 and a 200-day moving average price of $21.02.

About CellaVision AB (publ)

(Get Free Report)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.

Further Reading

Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.